A procedure is described for immunizing in vitro and stimulating proliferation of specific B-cell lymphocytes. The method is applicable to production of monoclonal antibodies against proteins that are soluble only in denaturing solvents. An induction period is described in which antigen is presented to the B-cell population in the absence of serum. Also, antigen is coupled to mitogenic silica, which allows the effective presentation of both soluble and insoluble antigens. The results indicate hybridomas can be obtained that secrete IgMs directed against highly conserved or weakly immunogenic antigens.
Now that the potential applications of hybridoma technology are appreciated (for review, see ref. 1) , the coupling of in vitro stimulation of lymphocytes to hybridoma production is of great importance, as in vitro immunization has several advantages over in vivo methods. For example, (i) it is possible to produce antibodies directed against highly conserved or weakly immunogenic determinants (2), (ii) comparatively little antigen is required (3) , and (iii) in vitro stimulation (4, 5) will in many cases be the procedure required to generate hybridomas secreting human antibodies. Considerable advances have been made recently in coupling the two procedures (2); however, several problems remain. The most significant is competition of introduced antigen with serum proteins or determinants in the rabbit or fetal calf serum required in most systems to support B-cell division (6) . Serumfree in vitro stimulation systems are known (7, 8) , but these rely on replacements which themselves include other proteins or immunogenic contaminants, and these systems are generally less supportive of B-cell division. Also, it has been difficult to introduce insoluble antigen into the in vitro stimulation reaction in a form that can be presented to the majority of lymphocytes or monocytes. Insoluble protein antigens either must be solubilized in cytotoxic solvents, which must be avoided during in vitro stimulation, or must be used as precipitates. Furthermore, the T-cell suppressor activity in the splenic cell population ideally should be eliminated, although it has been suggested that in vitro immunization is in part free of normal immune suppression (6, 9) . Here we describe studies directed at these problems.
METHODS
Coupling of Antigen to Silica. Metaphase chromosomes and nuclei were isolated from HeLa cells as described (10, 11) and associated nonhistone chromosomal proteins (NHCPs) were fractionated by NaDodSO4 gel electrophoresis (10) (11) (12) . Single bands in stained polyacrylamide gels (13) were cut from the gel with a razor blade. The protein was eluted from the gel slice essentially as described (14) by crushing the gel and mixing for hr with 1-5 ml of 2% NaDodSO4/1% 2-mercaptoethanol/5 mM Tris HCl, pH 7.2, and then was heated to 100'C for 2 min. The gel fragments were eliminated by centrifuging and filtering the solution through a Miller-HA filter (Millipore). Vimentin and a Mr 210,000 nucleolar protein were similarly prepared as single electrophoresis bands from HeLa cells. Total NHCPs were similarly solubilized in the above NaDodSO4 solution.
Fumed SiO2 (10-1000 .g; Sigma, size 0.007 ,um) suspended in water by sonication was then added to the solubilized protein and mixed for 12-24 hr at room temperature. Binding to the beads was usually rapid, but in some cases, to insure better binding, solid CCl3COOH was added to a final concentration of 25% (the latter step is required with certain proteins in NaDodSO4 solution). The silica beads with attached protein were collected by centrifugation (10,000 x g for 5 min) and washed repeatedly with distilled water to remove NaDodSO4 and/or CCl3COOH. More than 90% of all '25I-labeled NHCP or vimentin cosedimented with the silica.
Prior to use as an immunogen, the silica-antigen complex was briefly sonicated and could be sterilized by irradiation or autoclaving.
Summary of the in Vitro Stimulation Reaction. Spleen cells, thymocytes (isolated by screening through wire mesh), and macrophages were isolated (the latter by peritoneal cavity wash) from four or five BALB/c mice or C57/B1 x BALB/c F1 hybrids (see refs. 16 and 17) . Then, two sets of media were constructed. First, 5.0 ml of RPMI 1640 medium containing 40o fetal calf serum and all of the components described in Table 2 was thymocyte-conditioned by growing with 2 x 108 autologous thymocytes per ml. Second, 8 Table 2 , the other reaction (Exp. 1) undergoing the specified induction period (hours specified in the absence of fetal calf serum) prior to the addition of allogenic thymocyte-conditioned fetal calf serum. After 7-9 days of growth, the lymphocytes were fused to PAI/O myeloma cells, and hybridomas were grown in 96-well microtiter dishes.
Wells positive for growth were screened for antibody secretion by filtering culture supernatants through nitrocellulose paper using a filtration manifold (Schleicher & Schuell). The nitrocellulose sheet was then probed for absorbed mouse antibodies by incubating with 2
x 106 cpm of "2I-labeled sheep anti-mouse IgG (Fab fragment;
Amersham) as described (11) . The dried nitrocellulose sheet was exposed to x-ray film to identify by autoradiography dots corresponding to antibody-producing hybridomas. Antibodies directed against specific proteins were further screened by using a similar "dot-blot" assay in which the purified protein immobilized on nitrocellulose was incubated in the manifold with hybridoma supernatants and washed, and then the entire sheet was incubated with 125I-labeled sheep anti-mouse IgG, all as just described. Hybridomas screening as positive for chromosomal proteins were further screened for specific binding of antibodies-to nuclei or chromosomes by an immunofluorescence assay using fixed, permeabilized HeLa cells as described (11) . Specificity of all of the anti-sc-1 and some of the antivimentin antibodies was confirmed by using the immunoblot assay (see Fig. 1 ). The number of specific clones described above are those secreting antibody (which average 20-30%o of total clones) binding only the specific protein (sc-i or vimentin) in the above assays. In the case of Cu+2-NHCP, specificity to nuclear antigens was determined only with the immunofluorescence assay.
The introduction of silica alone stimulated lymphocytes to divide (ref. 21 , Table 2 ). The basis for the mitogenic activity of silica may be the indirect activation of macrophages as suggested (21) , but this point remains unclear. Excessive free silica is cytotoxic. The maximum amount tolerated was 500 ,ug per 108 spleen cells, as also previously found (21) .
Assembly of Reaction Components. It was anticipated that the maximal response to a specific antigen might be obtained when the antigen was presented in the absence of the milieu of serum proteins. An induction or priming period was devised during which antigen was presented to the lymphocyte population in the absence of serum, but after which thymocyte-conditioned medium containing serum was added to support growth. Lymphocytes were cultured in the absence of serum for up to 9 hr without affecting significantly the final number of responding and dividing cells, but the repertoire of resulting hybridomas was altered. Induction in the absence of fetal calf serum was required for production of significant numbers of clones specific for sc-i protein (Table  1 ). In four separate attempts to produce sc-i-specific hybridomas, none were obtained when immunization was in the presence of fetal calf serum without the induction period, and many were obtained when the induction in the absence of fetal calf serum was used. However, the possibility that the induction period might be less important at high concentrations of antigen has not been investigated. Although the number of clones specific for vimentin-or copper-stabilized NHCP was increased by the use of the induction period, substantial numbers of clones specific to the antigens also were observed without the fetal calf serum-free induction period. Since sc-i protein is a relatively weak immunogen and the other tested proteins are stronger (see below), studies to see if the apparent correlation between the value of serum-free priming and immunogenicity of the antigen is observed should be carried out.
Components of the Reaction. Table 2 summarizes the relative effects of growth-supporting factors and antisuppressor T-cell drugs. It has been shown that suppressor T cells, which are normal components of the spleen cell population, are capable of inhibiting specific antibody production in vitro (22) . Inhibition of suppressor T-cell activity would be of obvious value, especially when attempting to generate a response to highly conserved protein. Cimetidine acts on suppressor T cells bearing the surface receptor designated H2, which are histamine binding (23, 24) and may abrogate the suppressor effect (27) . 1,1-Dimethylhydrazine and hydrocortisone are used to generate a wider spectrum of antisuppressor activity, while at low concentrations leaving B-cells unaffected (28, 29) . Glutathione and 2-mercaptoethanol are added as growth factors (21, 30) . Nonessential amino acids, glutamine, and pyruvate are commonly used as lymphocyte supporting factors (6) . In different experiments, the added nucleosides increased the yield of stimulated cells by 2-to 6-fold. The addition of thymocyte-conditioned medium after the priming period was absolutely required to support lymphocyte division. Cell concentration was important. Optimal response occurred at spleen cell concentrations of 1 x 108 to 6 x 108 cells per 25 cm2. At lower cell concentrations, the number of stimulated cells fell quickly to 10% of maximal (data not shown).
Directing the Lymphocyte Response. Three specific antigens were studied with respect to (i) their ability to stimulate lymphocytes, (ii) their respective required concentration to elicit response, and (iii) the effects of the purity of the introduced antigen on specific response (Table 3) . The antigens differed greatly in their ability to stimulate lymphocytes. There was, for example, an apparent difference of 104 in molar concentration of antigen required to obtain a reasonable probability of obtaining an anti-sc-1 clone compared with obtaining an anti-vimentin clone. When the data were normal- When complex mixtures of antigens are presented to lymphocytes in vitro, response to certain antigens is reduced. To examine this, Cu2+-fixed NHCPs were tested, as this protein population consists essentially of all chromosomal proteins (58 as detected by electrophoresis) devoid of histones and proteins unable to be crosslinked by Cu2+ (10) . Although sc-1 protein represents one of the major protein components of Cu+2-fixed NHCPs (10) , the ability of sc-i to act as an immunogen was reduced in the presence of other proteins. For example, one can compare the number of sc-l-specific hybridomas produced when purified sc-i was used as immunogen or when an equivalent amount of sc-i mixed with other NHCPs was used instead. Since sc-1 comprised 5-10% of the total NHCPs, it seems that the immunogenicity of sc-i was masked by or in competition with the other proteins. Therefore, purified antigen was used when possible. Stimulating spleen cells with complex mixtures of NHCPs resulted in complex patterns of hybridoma activities, with the exception of a preponderance of antibodies directed against the nucleolus (30-35% of different activities) and diverse cytoplasmic antigens (40-45%) (data not shown).
Characterization of Producing Hybridomas and Antibodies.
The in vitro stimulation of lymphocytes induced only a primary response; hence, >99% of all the hybridomas obtained by in vitro stimulation protocols secreted IgM (Table 3) . We produced IgG-secreting hybridomas but at present cannot rule out the possibility that a preexisting activity in the mouse spleen cell population was immortalized. IgM-secreting hybridomas are stable; twice-cloned hybridomas have been cultured for 6 months continuously without diminution of activity. Monoclonal antibodies produced by this procedure were specific for respective immunogens by the different assays described in Table 1 . For example, an immunoblot analysis of total human chromosomal proteins using a typical anti-sc-i antibody showed a clear reaction with a protein having the electrophoretic mobility of sc-i but no detectable reaction with any other protein (Fig. 1) . Most of the antibodies recognizing other antigens had similar specificity to a single protein. The antibodies generally were applicable to many experiments requiring precise recognition of a specific protein. For example, antibodies tagged with colloidal gold or with fluorescence were used to localize the intranuclear and intrachromosomal positions of sc-1 protein via electron and fluorescence microscopy. These studies will be described elsewhere. Antibodies directed against sc-1, the Mr 210,000 nucleolar antigen, or vimentin reacted with antigens present in all mammalian cell lines tested in the immunofluorescence assay. These cell lines included human (HeLa 53; CCL 2.2), Chinese hamster ovary cell (CHO-Ki; CCL 2.2), and mouse (X63-AG8.6.5.3). For example, 18 of 19 different anti-nucleolar and anti-nuclear-chromosomal antigen-specific antibodies reacted across a spectrum of mammalian species, as did nine of nine antibodies specific for cytoplasmic antigens. When these results were compared with the activities of hybridomas produced from in vivo immunization with identical antigens, a notable difference was seen. On average, only 50% of anti-nuclear/nucleolar activities reacted across species lines, and anti-chromosomal activities were rarely obtained (1% of producing clones when NHCPs were used as antigen; unpublished data). Similar results after in vivo immunization have been described (32 (2) . We have been largely unsuccessful at attempts to obtain IgG-secreting hybridomas by extended culture but other protocols can be suggested.
Recently, preliminary results with this procedure in collaboration with Peter Brams and Karen Linnet in the laboratory of Lennart Olsson at the State University Hospital in Copenhagen have indicated that highly specific monoclonal antibodies were obtained against a mammalian core histone and a subunit of the insulin receptor. Thus, it appears this procedure is applicable to other insoluble and weak immunogens derived from both chromosomes and membranes.
